Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

BDNF Release Is Required for the Behavioral Actions of Ketamine
Ashley E. Lepack, Manabu Fuchikami, J. M. Dwyer, et al.
The International Journal of Neuropsychopharmacology (2014) Vol. 18, Iss. 1, pp. pyu033-pyu033
Open Access | Times Cited: 343

Showing 1-25 of 343 citing articles:

NMDAR inhibition-independent antidepressant actions of ketamine metabolites
Panos Zanos, Ruin Moaddel, Patrick J. Morris, et al.
Nature (2016) Vol. 533, Iss. 7604, pp. 481-486
Open Access | Times Cited: 1380
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
Stephen Ross, Anthony P. Bossis, Jeffrey Guss, et al.
Journal of Psychopharmacology (2016) Vol. 30, Iss. 12, pp. 1165-1180
Open Access | Times Cited: 1340
Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
Panos Zanos, Ruin Moaddel, Patrick J. Morris, et al.
Pharmacological Reviews (2018) Vol. 70, Iss. 3, pp. 621-660
Open Access | Times Cited: 942
Mechanisms of ketamine action as an antidepressant
Panos Zanos, Todd D. Gould
Molecular Psychiatry (2018) Vol. 23, Iss. 4, pp. 801-811
Open Access | Times Cited: 895
Psychedelics Promote Structural and Functional Neural Plasticity
Calvin Ly, Alexandra C. Greb, Lindsay P. Cameron, et al.
Cell Reports (2018) Vol. 23, Iss. 11, pp. 3170-3182
Open Access | Times Cited: 826
BDNF – a key transducer of antidepressant effects
Carl Björkholm, Lisa M. Monteggia
Neuropharmacology (2015) Vol. 102, pp. 72-79
Open Access | Times Cited: 825
Altered Connectivity in Depression: GABA and Glutamate Neurotransmitter Deficits and Reversal by Novel Treatments
Ronald S. Duman, Gerard Sanacora, John H. Krystal
Neuron (2019) Vol. 102, Iss. 1, pp. 75-90
Open Access | Times Cited: 775
Neurotrophic Factor BDNF, Physiological Functions and Therapeutic Potential in Depression, Neurodegeneration and Brain Cancer
Luca Colucci-D’Amato, Luisa Speranza, Floriana Volpicelli
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 20, pp. 7777-7777
Open Access | Times Cited: 643
R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects
Chun Yang, Yukihiko Shirayama, Ji‐chun Zhang, et al.
Translational Psychiatry (2015) Vol. 5, Iss. 9, pp. e632-e632
Open Access | Times Cited: 532
Pathogenesis of depression: Insights from human and rodent studies
Caroline Ménard, Georgia E. Hodes, Scott J. Russo
Neuroscience (2015) Vol. 321, pp. 138-162
Open Access | Times Cited: 487
Dendritic structural plasticity and neuropsychiatric disease
Marc P. Forrest, Euan Parnell, Peter Penzes
Nature reviews. Neuroscience (2018) Vol. 19, Iss. 4, pp. 215-234
Open Access | Times Cited: 423
Cortical GABAergic Dysfunction in Stress and Depression: New Insights for Therapeutic Interventions
Manoela V. Fogaça, Ronald S. Duman
Frontiers in Cellular Neuroscience (2019) Vol. 13
Open Access | Times Cited: 311
Brain-derived neurotrophic factor in mood disorders and antidepressant treatments
Eero Ċastrén, Masami Kojima
Neurobiology of Disease (2016) Vol. 97, pp. 119-126
Closed Access | Times Cited: 305
Rapid‐acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective
Kenji Hashimoto
Psychiatry and Clinical Neurosciences (2019) Vol. 73, Iss. 10, pp. 613-627
Open Access | Times Cited: 286
Emerging treatment mechanisms for depression: focus on glutamate and synaptic plasticity
Danielle M. Gerhard, Eric S. Wohleb, Ronald S. Duman
Drug Discovery Today (2016) Vol. 21, Iss. 3, pp. 454-464
Open Access | Times Cited: 266
Role of BDNF in the pathophysiology and treatment of depression: Activity‐dependent effects distinguish rapid‐acting antidepressants
Ronald S. Duman, Satoshi Deyama, Manoela V. Fogaça
European Journal of Neuroscience (2019) Vol. 53, Iss. 1, pp. 126-139
Open Access | Times Cited: 253
Spine synapse remodeling in the pathophysiology and treatment of depression
Catharine H. Duman, Ronald S. Duman
Neuroscience Letters (2015) Vol. 601, pp. 20-29
Open Access | Times Cited: 241
Neuronal plasticity and neurotrophic factors in drug responses
Eero Ċastrén, Hanna Antila
Molecular Psychiatry (2017) Vol. 22, Iss. 8, pp. 1085-1095
Open Access | Times Cited: 238
Neurotrophin signalling: novel insights into mechanisms and pathophysiology
Mariela Mitre, Abigail Mariga, Moses V. Chao
Clinical Science (2016) Vol. 131, Iss. 1, pp. 13-23
Open Access | Times Cited: 237
BDNF in sleep, insomnia, and sleep deprivation
Karen Schmitt, Edith Holsboer‐Trachsler, Anne Eckert
Annals of Medicine (2016) Vol. 48, Iss. 1-2, pp. 42-51
Closed Access | Times Cited: 214
The neurobiology of depression, ketamine and rapid-acting antidepressants: Is it glutamate inhibition or activation?
Chadi G. Abdallah, Gerard Sanacora, Ronald S. Duman, et al.
Pharmacology & Therapeutics (2018) Vol. 190, pp. 148-158
Open Access | Times Cited: 198
BDNF at the synapse: why location matters
Minseok Song, Keri Martinowich, Francis S. Lee
Molecular Psychiatry (2017) Vol. 22, Iss. 10, pp. 1370-1375
Open Access | Times Cited: 183
Disinhibition of CA1 pyramidal cells by low-dose ketamine and other antagonists with rapid antidepressant efficacy
Allie J. Widman, Lori L. McMahon
Proceedings of the National Academy of Sciences (2018) Vol. 115, Iss. 13
Open Access | Times Cited: 181
Ketamine and rapid-acting antidepressants: a new era in the battle against depression and suicide
Ronald S. Duman
F1000Research (2018) Vol. 7, pp. 659-659
Open Access | Times Cited: 177
KETAMINE'S MECHANISM OF ACTION: A PATH TO RAPID‐ACTING ANTIDEPRESSANTS
Chadi G. Abdallah, Thomas G. Adams, Benjamin Kelmendi, et al.
Depression and Anxiety (2016) Vol. 33, Iss. 8, pp. 689-697
Open Access | Times Cited: 175
Page 1 - Next Page

Scroll to top